Hartfalen: epidemiologie, risicofactoren en toekomst

RIVM Rapport 260401006
Barasch E, Gottdiener JS, Aurigemma G, Kitzman DW, Han J, Kop WJ, Tracy RP
(2009). Association between elevated fibrosis markers and heart failure in
the elderly: the cardiovascular health study. Circ Heart Fail 2, 303-10.
Barker WH, Mullooly JP, Getchell W (2006). Changing incidence and survival for
heart failure in a well-defined older population, 1970-1974 and 1990-1994.
Circulation 113, 799-805.
Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D,
Stoyanovsky V, Antikainen RL, Nikitin Y, Anderson C, Belhani A, Forette F,
Rajkumar C, Thijs L, Banya W, Bulpitt CJ (2008). Treatment of hypertension
in patients 80 years of age or older. N Engl J Med 358, 1887-98.
Bell DS (2003). Heart failure: the frequent, forgotten, and often fatal
complication of diabetes. Diabetes Care 26, 2433-41.
Bella JN, Maccluer JW, Roman MJ, Almasy L, North KE, Best LG, Lee ET, Fabsitz
RR, Howard BV, Devereux RB (2004). Heritability of left ventricular
dimensions and mass in American Indians: The Strong Heart Study. J
Hypertens 22, 281-6.
Bemelmans WJE, Wendel-Vos GCW, Bogers RP, Milder IEJ, de Hollander EL,
Barte JCM, Tariq L, Jacobs-van der Bruggen MAM (2008). Kosteneffectiviteit
beweeg- en dieetadvisering bij mensen met (hoog risico op) diabetes mellitus
type 2. Literatuuronderzoek en modelsimulaties rondom de Beweegkuur.
RIVM rapport 260401005. Bilthoven.
Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S,
Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisen J (2009).
Evidence for cardiomyocyte renewal in humans. Science 324, 98-102.
Betti I, Castelli G, Barchielli A, Beligni C, Boscherini V, De Luca L, Messeri G,
Gheorghiade M, Maisel A, Zuppiroli A (2009). The role of N-terminal PRObrain
natriuretic peptide and echocardiography for screening asymptomatic
left ventricular dysfunction in a population at high risk for heart failure. The
PROBE-HF study. J Card Fail 15, 377-84.
Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP (2006).
Outcome of heart failure with preserved ejection fraction in a populationbased
study. N Engl J Med 355, 260-9.
Bibbins-Domingo K, Pletcher MJ, Lin F, Vittinghoff E, Gardin JM, Arynchyn A,
Lewis CE, Williams OD, Hulley SB (2009). Racial differences in incident heart
failure among young adults. N Engl J Med 360, 1179-90.
Bielen E, Fagard R, Amery A (1991). The inheritance of left ventricular structure
and function assessed by imaging and Doppler echocardiography. Am Heart J
121, 1743-9.
Björk L, Rosengren A, Bennett K, Lappas G, Capewell S (2009). Modelling the
decreasing coronary heart disease mortality in Sweden between 1986 and
2002. Eur Heart J 30, 1046-56.
Blacher J, Evans A, Arveiler D, Amouyel P, Ferrieres J, Bingham A, Yarnell J,
Haas B, Montaye M, Ruidavets JB, Ducimetiere P (2010). Residual
cardiovascular risk in treated hypertension and hyperlipidaemia: the PRIME
Study. J Hum Hypertens 24, 19-26.
Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW,
Witteman JC, Stricker BH (2004). Quantifying the heart failure epidemic:
prevalence, incidence rate, lifetime risk and prognosis of heart failure The
Rotterdam Study. Eur Heart J 25, 1614-9.
Bogers RP, Barte JCM, Schipper CM, Vijgen SM, de Hollander EL, Tariq L, Milder
IE, Bemelmans WJ (2010). Relationship between costs of lifestyle
interventions and weight loss in overweight adults. Obesity reviews 11:51-
61.
Pagina 96 van 122